- Home
- CBL vs ORIC Comparison
CBL vs ORIC Comparison
Compare CBL & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBL
- ORIC
- Stock Information
- Founded
- CBL 1978
- ORIC 2014
- Country
- CBL United States
- ORIC United States
- Employees
- CBL 469
- ORIC N/A
- Industry
- CBL Real Estate Investment Trusts
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- CBL Real Estate
- ORIC Health Care
- Exchange
- CBL Nasdaq
- ORIC Nasdaq
- Market Cap
- CBL 961.6M
- ORIC 735.3M
- IPO Year
- CBL 1993
- ORIC 2020
- Fundamental
- Price
- CBL $31.31
- ORIC $7.68
- Analyst Decision
- CBL
- ORIC Strong Buy
- Analyst Count
- CBL 0
- ORIC 10
- Target Price
- CBL N/A
- ORIC $19.13
- AVG Volume (30 Days)
- CBL 177.2K
- ORIC 1.6M
- Earning Date
- CBL 02-14-2025
- ORIC 02-18-2025
- Dividend Yield
- CBL 8.96%
- ORIC N/A
- EPS Growth
- CBL 999.46
- ORIC N/A
- EPS
- CBL 1.87
- ORIC N/A
- Revenue
- CBL $515,561,000.00
- ORIC N/A
- Revenue This Year
- CBL N/A
- ORIC N/A
- Revenue Next Year
- CBL N/A
- ORIC N/A
- P/E Ratio
- CBL $17.08
- ORIC N/A
- Revenue Growth
- CBL N/A
- ORIC N/A
- 52 Week Low
- CBL $20.97
- ORIC $6.33
- 52 Week High
- CBL $33.54
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- CBL 56.57
- ORIC 36.65
- Support Level
- CBL $31.37
- ORIC $7.34
- Resistance Level
- CBL $32.37
- ORIC $14.67
- Average True Range (ATR)
- CBL 0.80
- ORIC 1.56
- MACD
- CBL 0.11
- ORIC -0.45
- Stochastic Oscillator
- CBL 38.65
- ORIC 4.64
About CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a U.S.-based real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.